Ocugen GA Trial Advances Toward Phase 3
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
False
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
By Rod Solar
April 30, 2026
You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey
4 min read
By Nandini Venkateswaran
April 30, 2026
What surgeons need to know about managing post-cataract inflammation
3 min read
By
April 27, 2026
Should refractive surgery precision always have to come at a price? Evaluating cost, consistency, and learning curves in astigmatism correction
3 min read
By Michael Mikhail,
April 22, 2026
How an intensive phacoemulsification training program helped develop advanced ophthalmic procedures in the country
4 min read
By
April 16, 2026
As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care
4 min read
By Sumrana Yasmin, Emma Jolley
April 15, 2026
Why action is needed to embed better eye care practices throughout Africa and Asia
4 min read
By Benjamin Stern
April 14, 2026
How advances in physics-informed optical modeling will reshape how surgeons select intraocular lenses and plan refractive cataract outcomes in the near future
4 min read
By Dr. Mohamed Tawfik
April 1, 2026
Why ophthalmic care and resources are desperately needed in Gaza right now
2 min read
By Jerry Robben
March 27, 2026
The dental profession long ago decided it was important to preach preventative maintenance for everyone. We should do the same
7 min read
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: